LINC02500

Across TCGA pan-cancer cohorts, LINC02500 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC02500 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC02500 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02500 expression acts as an unfavorable survival marker, although some lineages such as OV and LGG show a favorable association.

COAD, KIRP, and LUAD are the cancer types where LINC02500 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	III,IV	0.204	0.786	<.001	117	view →
KIRP	OS	Tertile	All	0.141	0.904	<.001	108	view →
LUAD	OS	Tertile	III,IV	0.083	0.670	<.001	108	view →
LIHC	OS	Tertile	II,III,IV	0.051	0.716	<.001	72	view →
CESC	OS	Tertile	III,IV	0.091	0.755	<.001	72	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	54	view →
OV	DFS	Tertile	IV	0.960	0.424	.028	18	view →
LGG	DFS	Tertile	All	0.896	0.800	.001	18	view →
PCPG	DFS	Tertile	All	0.982	0.828	.008	13	view →
PAAD	DFS	Tertile	All	1.000	0.266	.016	9	view →
SKCM	DFS	Tertile	All	0.248	0.642	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC02500–COAD (OS)

Open the COAD breakdown →